Epithelial-mesenchymal transition expression profiles as a prognostic factor for disease-free survival in hepatocellular carcinoma: Clinical significance of transforming growth factor-β signaling

By                  

Oncology Letters, Vol. 5, Iss. 1, 2013-01 ,pp. : 149-154

Spandidos Publications

Access to resources Recommend Favorite

Expression of Decorin in Esophageal Cancer in Relation to the Expression of Three Isoforms of Transforming Growth Factor-Beta (TGF-β1, -β2, and -β3) and Matrix Metalloproteinase-2 Activity

By Augoff K.   Grabowski K.   Rabczynski J.   Kolondra A.   Tabola R.   Sikorski A. F.  

Cancer Investigation, Vol. 27, Iss. 4, 2009-05 ,pp. : 443-452

Informa Healthcare

Access to resources Recommend Favorite

Elevated plasma levels of transforming growth factor- 1 (TGF- 1 ) in patients with advanced breast cancer: association with disease progression

By Ivanovic V.   Todorovic-Rakovic N.   Demajo M.   Neskovic-Konstantinovic Z.   Subota V.   Ivanisevic-Milovanovic O.   Nikolic-Vukosavljevic D.  

European Journal of Cancer, Vol. 39, Iss. 4, 2003-03 ,pp. : 454-461

Elsevier

Access to resources Recommend Favorite

Circulating levels of vascular endothelial growth factor (VEGF), matrix metalloproteinase-3 (MMP-3), and BCL-2 in malignant melanoma

By Tas Faruk   Duranyildiz Derya   Oguz Hilal   Camlica Hakan   Yasasever Vildan   Topuz Erkan  

Medical Oncology, Vol. 25, Iss. 4, 2008-12 ,pp. : 431-436

Humana Press, Inc

Access to resources Recommend Favorite

Chondrogenic differentiation of canine myoblasts induced by cartilage-derived morphogenetic protein-2 and transforming growth factor-β1 in vitro

By            

Molecular Medicine Reports, Vol. 5, Iss. 3, 2012-01 ,pp. : 767-772

Spandidos Publications

Access to resources Recommend Favorite